Analystreport

Sorrento Therapeutics Inc (NASDAQ: SRNE) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Sorrento Therapeutics, Inc.  (SRNE) 
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm Check Earnings Report
US:NASDAQ Investor Relations: sorrentotherapeutics.com/investors